broadly neutralizing antibodies
Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs
20
Activity of Broadly Neutralizing Antibodies, Including PG9, PG16, and VRC01, against Recently Transmitted Subtype B HIV-1 Variants from Early and Late in the Epidemic
10
Importance of Fc mediated functions of anti HIV 1 broadly neutralizing antibodies
12
Selection Pressure on HIV-1 Envelope by Broadly Neutralizing Antibodies to the Conserved CD4-Binding Site
13
Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance
18
Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies
16
HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies
8
Antibody Response to Hypervariable Region 1 Interferes with Broadly Neutralizing Antibodies to Hepatitis C Virus
11
Development of broadly neutralizing antibodies in HIV 1 infected elite neutralizers
14
Norovirus Escape from Broadly Neutralizing Antibodies Is Limited to Allostery-Like Mechanisms
19
Broadly neutralizing antibodies targeted to mucin-type carbohydrate epitopes of human immunodeficiency virus.
7
Challenges on Induction of Broadly Neutralizing Antibodies for Optimization of HIV Vaccines Development and Vectored Immunoprophylaxis
5
Mechanisms of escape from the PGT128 family of anti HIV broadly neutralizing antibodies
15
Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance
12
A Vaccine Based on the Rhesus Cytomegalovirus UL128 Complex Induces Broadly Neutralizing Antibodies in Rhesus Macaques
11
Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques
15
Role of Human Immunodeficiency Virus Type 1 Envelope Structure in the Induction of Broadly Neutralizing Antibodies
12
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
6
Towards HIV 1 remission: potential roles for broadly neutralizing antibodies
10
HIV 1 cell to cell transmission and broadly neutralizing antibodies
14